nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—ABCC6—Dactinomycin—skin cancer	0.259	0.342	CbGbCtD
Teniposide—ABCG2—Vismodegib—skin cancer	0.0972	0.129	CbGbCtD
Teniposide—ABCG2—Vemurafenib—skin cancer	0.0768	0.102	CbGbCtD
Teniposide—ABCG2—Dactinomycin—skin cancer	0.051	0.0676	CbGbCtD
Teniposide—CYP2C19—Vismodegib—skin cancer	0.0434	0.0575	CbGbCtD
Teniposide—CYP2C9—Vismodegib—skin cancer	0.0361	0.0478	CbGbCtD
Teniposide—ABCG2—Fluorouracil—skin cancer	0.0345	0.0457	CbGbCtD
Teniposide—CYP3A4—Imiquimod—skin cancer	0.0303	0.0401	CbGbCtD
Teniposide—CYP3A4—Temozolomide—skin cancer	0.0303	0.0401	CbGbCtD
Teniposide—ABCG2—Docetaxel—skin cancer	0.0264	0.0349	CbGbCtD
Teniposide—CYP3A4—Vismodegib—skin cancer	0.021	0.0278	CbGbCtD
Teniposide—CYP3A4—Vemurafenib—skin cancer	0.0166	0.022	CbGbCtD
Teniposide—CYP3A5—Docetaxel—skin cancer	0.0146	0.0193	CbGbCtD
Teniposide—ABCC6—dermis—skin cancer	0.0141	0.237	CbGeAlD
Teniposide—CYP2C9—Fluorouracil—skin cancer	0.0128	0.017	CbGbCtD
Teniposide—NCOA1—hair follicle—skin cancer	0.00691	0.116	CbGeAlD
Teniposide—CYP3A4—Docetaxel—skin cancer	0.00569	0.00754	CbGbCtD
Teniposide—NCOA3—hair follicle—skin cancer	0.00481	0.081	CbGeAlD
Teniposide—NCOA1—nipple—skin cancer	0.00468	0.0788	CbGeAlD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—KRT17—skin cancer	0.00374	0.0825	CbGpPWpGaD
Teniposide—Acute myeloid leukaemia—Docetaxel—skin cancer	0.00368	0.027	CcSEcCtD
Teniposide—Cardiotoxicity—Fluorouracil—skin cancer	0.00355	0.0261	CcSEcCtD
Teniposide—NCOA3—nipple—skin cancer	0.00326	0.0549	CbGeAlD
Teniposide—NCOA3—neck—skin cancer	0.00323	0.0544	CbGeAlD
Teniposide—Acute leukaemia—Temozolomide—skin cancer	0.00317	0.0234	CcSEcCtD
Teniposide—Electrocardiogram change—Fluorouracil—skin cancer	0.00293	0.0215	CcSEcCtD
Teniposide—NCOA1—mammalian vulva—skin cancer	0.00274	0.046	CbGeAlD
Teniposide—Cardiotoxicity—Docetaxel—skin cancer	0.00256	0.0188	CcSEcCtD
Teniposide—NCOA3—connective tissue—skin cancer	0.00231	0.039	CbGeAlD
Teniposide—Myelosuppression—Bleomycin—skin cancer	0.00229	0.0169	CcSEcCtD
Teniposide—Raised liver function tests—Dactinomycin—skin cancer	0.00217	0.016	CcSEcCtD
Teniposide—Myelosuppression—Dactinomycin—skin cancer	0.00214	0.0157	CcSEcCtD
Teniposide—Acute leukaemia—Docetaxel—skin cancer	0.00211	0.0155	CcSEcCtD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.00204	0.0451	CbGpPWpGaD
Teniposide—ABCC6—connective tissue—skin cancer	0.00204	0.0343	CbGeAlD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—KRT5—skin cancer	0.00196	0.0434	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—ASIP—skin cancer	0.00196	0.0433	CbGpPWpGaD
Teniposide—Mucosal inflammation—Bleomycin—skin cancer	0.00194	0.0143	CcSEcCtD
Teniposide—Myelosuppression—Temozolomide—skin cancer	0.00193	0.0142	CcSEcCtD
Teniposide—TOP2A—nipple—skin cancer	0.00191	0.0322	CbGeAlD
Teniposide—TOP2A—Sorafenib—Vismodegib—skin cancer	0.00191	0.584	CbGdCrCtD
Teniposide—NCOA3—mammalian vulva—skin cancer	0.00191	0.0321	CbGeAlD
Teniposide—Nephropathy toxic—Bleomycin—skin cancer	0.00187	0.0138	CcSEcCtD
Teniposide—NCOA3—FOXA1 transcription factor network—SHH—skin cancer	0.00187	0.0413	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—KRT14—skin cancer	0.00183	0.0403	CbGpPWpGaD
Teniposide—Myelosuppression—Fluorouracil—skin cancer	0.00178	0.0131	CcSEcCtD
Teniposide—NCOA3—lymphoid tissue—skin cancer	0.00169	0.0285	CbGeAlD
Teniposide—NCOA3—PPARA activates gene expression—PLIN2—skin cancer	0.00164	0.0362	CbGpPWpGaD
Teniposide—Sudden death—Fluorouracil—skin cancer	0.00163	0.012	CcSEcCtD
Teniposide—NCOA3—female reproductive system—skin cancer	0.00163	0.0275	CbGeAlD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT5—skin cancer	0.00162	0.0359	CbGpPWpGaD
Teniposide—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.00161	0.0354	CbGpPWpGaD
Teniposide—Neoplasm—Vemurafenib—skin cancer	0.00161	0.0118	CcSEcCtD
Teniposide—Neurotoxicity—Docetaxel—skin cancer	0.00156	0.0114	CcSEcCtD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT14—skin cancer	0.00151	0.0333	CbGpPWpGaD
Teniposide—NCOA1—lymph node—skin cancer	0.00137	0.0231	CbGeAlD
Teniposide—NCOA3—head—skin cancer	0.00136	0.023	CbGeAlD
Teniposide—TOP2A—Paclitaxel—Docetaxel—skin cancer	0.00136	0.416	CbGdCrCtD
Teniposide—NCOA1—PPARA activates gene expression—PLIN2—skin cancer	0.00136	0.03	CbGpPWpGaD
Teniposide—NCOA1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.00133	0.0293	CbGpPWpGaD
Teniposide—Raised liver function tests—Docetaxel—skin cancer	0.00131	0.00961	CcSEcCtD
Teniposide—Myelosuppression—Docetaxel—skin cancer	0.00129	0.00947	CcSEcCtD
Teniposide—Alopecia—Vismodegib—skin cancer	0.00128	0.00938	CcSEcCtD
Teniposide—Hepatic function abnormal—Imiquimod—skin cancer	0.00126	0.00925	CcSEcCtD
Teniposide—Extravasation—Bleomycin—skin cancer	0.00123	0.00907	CcSEcCtD
Teniposide—ABCC6—head—skin cancer	0.0012	0.0202	CbGeAlD
Teniposide—NCOA1—Adipogenesis—PLIN2—skin cancer	0.00119	0.0262	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—XRCC3—skin cancer	0.00115	0.0254	CbGpPWpGaD
Teniposide—Extravasation—Dactinomycin—skin cancer	0.00115	0.00846	CcSEcCtD
Teniposide—TOP2A—mammalian vulva—skin cancer	0.00112	0.0188	CbGeAlD
Teniposide—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.00111	0.0244	CbGpPWpGaD
Teniposide—Mucosal inflammation—Docetaxel—skin cancer	0.00109	0.00802	CcSEcCtD
Teniposide—ABCG2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00104	0.0229	CbGpPWpGaD
Teniposide—Neuropathy peripheral—Vemurafenib—skin cancer	0.000973	0.00716	CcSEcCtD
Teniposide—Extravasation—Fluorouracil—skin cancer	0.000958	0.00705	CcSEcCtD
Teniposide—NCOA3—lymph node—skin cancer	0.000955	0.0161	CbGeAlD
Teniposide—NCOA1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.000915	0.0202	CbGpPWpGaD
Teniposide—Etoposide—PTGS2—skin cancer	0.000911	1	CrCbGaD
Teniposide—Phlebitis—Bleomycin—skin cancer	0.000906	0.00667	CcSEcCtD
Teniposide—Pancytopenia—Imiquimod—skin cancer	0.000902	0.00664	CcSEcCtD
Teniposide—Decreased appetite—Vismodegib—skin cancer	0.000891	0.00656	CcSEcCtD
Teniposide—Sepsis—Dactinomycin—skin cancer	0.00087	0.0064	CcSEcCtD
Teniposide—Neuropathy—Temozolomide—skin cancer	0.000852	0.00627	CcSEcCtD
Teniposide—Phlebitis—Dactinomycin—skin cancer	0.000845	0.00622	CcSEcCtD
Teniposide—Gastrointestinal pain—Vismodegib—skin cancer	0.000838	0.00617	CcSEcCtD
Teniposide—Neuropathy peripheral—Imiquimod—skin cancer	0.00083	0.00611	CcSEcCtD
Teniposide—Neoplasm—Temozolomide—skin cancer	0.00082	0.00604	CcSEcCtD
Teniposide—Abdominal pain—Vismodegib—skin cancer	0.00081	0.00596	CcSEcCtD
Teniposide—Chills—Vemurafenib—skin cancer	0.0008	0.00589	CcSEcCtD
Teniposide—Alopecia—Vemurafenib—skin cancer	0.000788	0.0058	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—FOXO4—skin cancer	0.000774	0.0171	CbGpPWpGaD
Teniposide—Haemoglobin—Imiquimod—skin cancer	0.000764	0.00562	CcSEcCtD
Teniposide—Haemorrhage—Imiquimod—skin cancer	0.00076	0.00559	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—MSH2—skin cancer	0.000742	0.0164	CbGpPWpGaD
Teniposide—Asthenia—Vismodegib—skin cancer	0.000736	0.00541	CcSEcCtD
Teniposide—Sepsis—Fluorouracil—skin cancer	0.000725	0.00534	CcSEcCtD
Teniposide—Pruritus—Vismodegib—skin cancer	0.000725	0.00534	CcSEcCtD
Teniposide—Flushing—Imiquimod—skin cancer	0.000706	0.00519	CcSEcCtD
Teniposide—Diarrhoea—Vismodegib—skin cancer	0.000701	0.00516	CcSEcCtD
Teniposide—Extravasation—Docetaxel—skin cancer	0.000692	0.00509	CcSEcCtD
Teniposide—Chills—Imiquimod—skin cancer	0.000682	0.00502	CcSEcCtD
Teniposide—Arrhythmia—Imiquimod—skin cancer	0.000679	0.005	CcSEcCtD
Teniposide—Liver function test abnormal—Dactinomycin—skin cancer	0.000672	0.00495	CcSEcCtD
Teniposide—Alopecia—Imiquimod—skin cancer	0.000672	0.00494	CcSEcCtD
Teniposide—Bronchospasm—Bleomycin—skin cancer	0.000664	0.00488	CcSEcCtD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.000659	0.0146	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—RASA1—skin cancer	0.000655	0.0145	CbGpPWpGaD
Teniposide—Vomiting—Vismodegib—skin cancer	0.000652	0.0048	CcSEcCtD
Teniposide—Rash—Vismodegib—skin cancer	0.000646	0.00476	CcSEcCtD
Teniposide—Dermatitis—Vismodegib—skin cancer	0.000646	0.00475	CcSEcCtD
Teniposide—Pancytopenia—Bleomycin—skin cancer	0.000641	0.00471	CcSEcCtD
Teniposide—Infection—Vemurafenib—skin cancer	0.000629	0.00463	CcSEcCtD
Teniposide—NCOA1—HIF-1-alpha transcription factor network—TERT—skin cancer	0.000609	0.0134	CbGpPWpGaD
Teniposide—Nausea—Vismodegib—skin cancer	0.000609	0.00448	CcSEcCtD
Teniposide—Agitation—Imiquimod—skin cancer	0.000608	0.00447	CcSEcCtD
Teniposide—Pancytopenia—Dactinomycin—skin cancer	0.000598	0.0044	CcSEcCtD
Teniposide—Hypotension—Vemurafenib—skin cancer	0.000592	0.00435	CcSEcCtD
Teniposide—Neutropenia—Dactinomycin—skin cancer	0.000588	0.00433	CcSEcCtD
Teniposide—Stomatitis—Bleomycin—skin cancer	0.000586	0.00431	CcSEcCtD
Teniposide—NCOA3—Transcriptional regulation of white adipocyte differentiation—CDK4—skin cancer	0.000583	0.0129	CbGpPWpGaD
Teniposide—Hypertension—Imiquimod—skin cancer	0.000571	0.0042	CcSEcCtD
Teniposide—Neuropathy—Docetaxel—skin cancer	0.000566	0.00417	CcSEcCtD
Teniposide—Chest pain—Imiquimod—skin cancer	0.000563	0.00415	CcSEcCtD
Teniposide—TOP2A—lymph node—skin cancer	0.00056	0.00943	CbGeAlD
Teniposide—ABCG2—mammalian vulva—skin cancer	0.000558	0.00938	CbGeAlD
Teniposide—Decreased appetite—Vemurafenib—skin cancer	0.000551	0.00405	CcSEcCtD
Teniposide—Stomatitis—Dactinomycin—skin cancer	0.000547	0.00402	CcSEcCtD
Teniposide—Neoplasm—Docetaxel—skin cancer	0.000545	0.00401	CcSEcCtD
Teniposide—Haemoglobin—Bleomycin—skin cancer	0.000543	0.00399	CcSEcCtD
Teniposide—Pancytopenia—Temozolomide—skin cancer	0.000541	0.00398	CcSEcCtD
Teniposide—Oedema—Imiquimod—skin cancer	0.00054	0.00397	CcSEcCtD
Teniposide—Haemorrhage—Bleomycin—skin cancer	0.00054	0.00397	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—FOXO4—skin cancer	0.000538	0.0119	CbGpPWpGaD
Teniposide—Infection—Imiquimod—skin cancer	0.000537	0.00395	CcSEcCtD
Teniposide—Neutropenia—Temozolomide—skin cancer	0.000532	0.00392	CcSEcCtD
Teniposide—Tachycardia—Imiquimod—skin cancer	0.000527	0.00388	CcSEcCtD
Teniposide—Sepsis—Docetaxel—skin cancer	0.000524	0.00385	CcSEcCtD
Teniposide—Hyperhidrosis—Imiquimod—skin cancer	0.000522	0.00384	CcSEcCtD
Teniposide—Anorexia—Imiquimod—skin cancer	0.000515	0.00379	CcSEcCtD
Teniposide—Phlebitis—Docetaxel—skin cancer	0.000508	0.00374	CcSEcCtD
Teniposide—Flushing—Bleomycin—skin cancer	0.000501	0.00369	CcSEcCtD
Teniposide—Body temperature increased—Vemurafenib—skin cancer	0.000501	0.00368	CcSEcCtD
Teniposide—Pancytopenia—Fluorouracil—skin cancer	0.000498	0.00366	CcSEcCtD
Teniposide—Neuropathy peripheral—Temozolomide—skin cancer	0.000497	0.00366	CcSEcCtD
Teniposide—Stomatitis—Temozolomide—skin cancer	0.000495	0.00364	CcSEcCtD
Teniposide—Chills—Bleomycin—skin cancer	0.000485	0.00357	CcSEcCtD
Teniposide—NCOA1—Transcriptional regulation of white adipocyte differentiation—CDK4—skin cancer	0.000482	0.0106	CbGpPWpGaD
Teniposide—Dyspnoea—Imiquimod—skin cancer	0.000482	0.00354	CcSEcCtD
Teniposide—Alopecia—Bleomycin—skin cancer	0.000477	0.00351	CcSEcCtD
Teniposide—Decreased appetite—Imiquimod—skin cancer	0.00047	0.00345	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—SCN10A—skin cancer	0.000468	0.0103	CbGpPWpGaD
Teniposide—Flushing—Dactinomycin—skin cancer	0.000467	0.00344	CcSEcCtD
Teniposide—Hypersensitivity—Vemurafenib—skin cancer	0.000467	0.00343	CcSEcCtD
Teniposide—NCOA1—Regulation of nuclear SMAD2/3 signaling—CDK4—skin cancer	0.000463	0.0102	CbGpPWpGaD
Teniposide—Neuropathy peripheral—Fluorouracil—skin cancer	0.000458	0.00337	CcSEcCtD
Teniposide—Haemoglobin—Temozolomide—skin cancer	0.000458	0.00337	CcSEcCtD
Teniposide—Stomatitis—Fluorouracil—skin cancer	0.000456	0.00335	CcSEcCtD
Teniposide—Haemorrhage—Temozolomide—skin cancer	0.000456	0.00335	CcSEcCtD
Teniposide—Asthenia—Vemurafenib—skin cancer	0.000454	0.00334	CcSEcCtD
Teniposide—ABCC6—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000454	0.01	CbGpPWpGaD
Teniposide—Chills—Dactinomycin—skin cancer	0.000452	0.00333	CcSEcCtD
Teniposide—Pruritus—Vemurafenib—skin cancer	0.000448	0.0033	CcSEcCtD
Teniposide—Alopecia—Dactinomycin—skin cancer	0.000445	0.00327	CcSEcCtD
Teniposide—Feeling abnormal—Imiquimod—skin cancer	0.000445	0.00327	CcSEcCtD
Teniposide—Gastrointestinal pain—Imiquimod—skin cancer	0.000442	0.00325	CcSEcCtD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000441	0.00973	CbGpPWpGaD
Teniposide—CYP2C9—female reproductive system—skin cancer	0.000436	0.00734	CbGeAlD
Teniposide—Anaemia—Bleomycin—skin cancer	0.000435	0.0032	CcSEcCtD
Teniposide—Diarrhoea—Vemurafenib—skin cancer	0.000433	0.00319	CcSEcCtD
Teniposide—Urticaria—Imiquimod—skin cancer	0.000429	0.00316	CcSEcCtD
Teniposide—Body temperature increased—Imiquimod—skin cancer	0.000427	0.00314	CcSEcCtD
Teniposide—Abdominal pain—Imiquimod—skin cancer	0.000427	0.00314	CcSEcCtD
Teniposide—Flushing—Temozolomide—skin cancer	0.000423	0.00311	CcSEcCtD
Teniposide—Haemoglobin—Fluorouracil—skin cancer	0.000422	0.0031	CcSEcCtD
Teniposide—TOP2A—Circadian rythm related genes—NKX2-1—skin cancer	0.000421	0.00929	CbGpPWpGaD
Teniposide—Leukopenia—Bleomycin—skin cancer	0.000421	0.0031	CcSEcCtD
Teniposide—Haemorrhage—Fluorouracil—skin cancer	0.00042	0.00309	CcSEcCtD
Teniposide—Chills—Temozolomide—skin cancer	0.000409	0.00301	CcSEcCtD
Teniposide—Anaemia—Dactinomycin—skin cancer	0.000405	0.00298	CcSEcCtD
Teniposide—Liver function test abnormal—Docetaxel—skin cancer	0.000404	0.00297	CcSEcCtD
Teniposide—Vomiting—Vemurafenib—skin cancer	0.000403	0.00296	CcSEcCtD
Teniposide—Alopecia—Temozolomide—skin cancer	0.000403	0.00296	CcSEcCtD
Teniposide—Chest pain—Bleomycin—skin cancer	0.0004	0.00295	CcSEcCtD
Teniposide—Rash—Vemurafenib—skin cancer	0.000399	0.00294	CcSEcCtD
Teniposide—Dermatitis—Vemurafenib—skin cancer	0.000399	0.00294	CcSEcCtD
Teniposide—Hypersensitivity—Imiquimod—skin cancer	0.000398	0.00293	CcSEcCtD
Teniposide—Headache—Vemurafenib—skin cancer	0.000397	0.00292	CcSEcCtD
Teniposide—Leukopenia—Dactinomycin—skin cancer	0.000393	0.00289	CcSEcCtD
Teniposide—Asthenia—Imiquimod—skin cancer	0.000388	0.00285	CcSEcCtD
Teniposide—Confusional state—Bleomycin—skin cancer	0.000387	0.00285	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—SCN10A—skin cancer	0.000387	0.00854	CbGpPWpGaD
Teniposide—Oedema—Bleomycin—skin cancer	0.000384	0.00282	CcSEcCtD
Teniposide—Pruritus—Imiquimod—skin cancer	0.000382	0.00281	CcSEcCtD
Teniposide—Infection—Bleomycin—skin cancer	0.000381	0.0028	CcSEcCtD
Teniposide—Nausea—Vemurafenib—skin cancer	0.000376	0.00277	CcSEcCtD
Teniposide—Thrombocytopenia—Bleomycin—skin cancer	0.000376	0.00276	CcSEcCtD
Teniposide—Arrhythmia—Fluorouracil—skin cancer	0.000375	0.00276	CcSEcCtD
Teniposide—Bronchospasm—Docetaxel—skin cancer	0.000372	0.00274	CcSEcCtD
Teniposide—Alopecia—Fluorouracil—skin cancer	0.000371	0.00273	CcSEcCtD
Teniposide—Diarrhoea—Imiquimod—skin cancer	0.00037	0.00272	CcSEcCtD
Teniposide—Anaemia—Temozolomide—skin cancer	0.000367	0.0027	CcSEcCtD
Teniposide—Anorexia—Bleomycin—skin cancer	0.000366	0.00269	CcSEcCtD
Teniposide—ABCG2—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000365	0.00806	CbGpPWpGaD
Teniposide—Agitation—Temozolomide—skin cancer	0.000364	0.00268	CcSEcCtD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000364	0.00805	CbGpPWpGaD
Teniposide—Pancytopenia—Docetaxel—skin cancer	0.000359	0.00264	CcSEcCtD
Teniposide—Hypotension—Bleomycin—skin cancer	0.000359	0.00264	CcSEcCtD
Teniposide—Oedema—Dactinomycin—skin cancer	0.000358	0.00263	CcSEcCtD
Teniposide—Infection—Dactinomycin—skin cancer	0.000356	0.00262	CcSEcCtD
Teniposide—Leukopenia—Temozolomide—skin cancer	0.000355	0.00261	CcSEcCtD
Teniposide—Neutropenia—Docetaxel—skin cancer	0.000354	0.0026	CcSEcCtD
Teniposide—Thrombocytopenia—Dactinomycin—skin cancer	0.00035	0.00258	CcSEcCtD
Teniposide—Vomiting—Imiquimod—skin cancer	0.000343	0.00253	CcSEcCtD
Teniposide—Hypertension—Temozolomide—skin cancer	0.000342	0.00252	CcSEcCtD
Teniposide—Dyspnoea—Bleomycin—skin cancer	0.000342	0.00252	CcSEcCtD
Teniposide—Anorexia—Dactinomycin—skin cancer	0.000341	0.00251	CcSEcCtD
Teniposide—Rash—Imiquimod—skin cancer	0.000341	0.00251	CcSEcCtD
Teniposide—Dermatitis—Imiquimod—skin cancer	0.00034	0.0025	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—CDK4—skin cancer	0.00034	0.00751	CbGpPWpGaD
Teniposide—Headache—Imiquimod—skin cancer	0.000338	0.00249	CcSEcCtD
Teniposide—Anaemia—Fluorouracil—skin cancer	0.000338	0.00249	CcSEcCtD
Teniposide—Decreased appetite—Bleomycin—skin cancer	0.000334	0.00245	CcSEcCtD
Teniposide—CYP3A4—female reproductive system—skin cancer	0.000333	0.0056	CbGeAlD
Teniposide—Neuropathy peripheral—Docetaxel—skin cancer	0.000331	0.00243	CcSEcCtD
Teniposide—Stomatitis—Docetaxel—skin cancer	0.000329	0.00242	CcSEcCtD
Teniposide—NCOA1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000328	0.00725	CbGpPWpGaD
Teniposide—Leukopenia—Fluorouracil—skin cancer	0.000327	0.00241	CcSEcCtD
Teniposide—Confusional state—Temozolomide—skin cancer	0.000326	0.0024	CcSEcCtD
Teniposide—Oedema—Temozolomide—skin cancer	0.000324	0.00238	CcSEcCtD
Teniposide—Infection—Temozolomide—skin cancer	0.000322	0.00237	CcSEcCtD
Teniposide—Nausea—Imiquimod—skin cancer	0.000321	0.00236	CcSEcCtD
Teniposide—Thrombocytopenia—Temozolomide—skin cancer	0.000317	0.00233	CcSEcCtD
Teniposide—Feeling abnormal—Bleomycin—skin cancer	0.000316	0.00233	CcSEcCtD
Teniposide—Hyperhidrosis—Temozolomide—skin cancer	0.000313	0.0023	CcSEcCtD
Teniposide—Chest pain—Fluorouracil—skin cancer	0.000311	0.00229	CcSEcCtD
Teniposide—Decreased appetite—Dactinomycin—skin cancer	0.000311	0.00229	CcSEcCtD
Teniposide—Anorexia—Temozolomide—skin cancer	0.000309	0.00227	CcSEcCtD
Teniposide—Urticaria—Bleomycin—skin cancer	0.000305	0.00224	CcSEcCtD
Teniposide—Haemoglobin—Docetaxel—skin cancer	0.000305	0.00224	CcSEcCtD
Teniposide—Body temperature increased—Bleomycin—skin cancer	0.000303	0.00223	CcSEcCtD
Teniposide—Haemorrhage—Docetaxel—skin cancer	0.000303	0.00223	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—BRAF—skin cancer	0.000301	0.00664	CbGpPWpGaD
Teniposide—Confusional state—Fluorouracil—skin cancer	0.000301	0.00221	CcSEcCtD
Teniposide—NCOA1—IL-6 signaling pathway—IL6—skin cancer	0.000299	0.0066	CbGpPWpGaD
Teniposide—Oedema—Fluorouracil—skin cancer	0.000298	0.00219	CcSEcCtD
Teniposide—Infection—Fluorouracil—skin cancer	0.000296	0.00218	CcSEcCtD
Teniposide—Feeling abnormal—Dactinomycin—skin cancer	0.000295	0.00217	CcSEcCtD
Teniposide—Gastrointestinal pain—Dactinomycin—skin cancer	0.000293	0.00215	CcSEcCtD
Teniposide—Thrombocytopenia—Fluorouracil—skin cancer	0.000292	0.00215	CcSEcCtD
Teniposide—Tachycardia—Fluorouracil—skin cancer	0.000291	0.00214	CcSEcCtD
Teniposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—skin cancer	0.00029	0.0064	CbGpPWpGaD
Teniposide—Dyspnoea—Temozolomide—skin cancer	0.000289	0.00212	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—BRAF—skin cancer	0.000284	0.00628	CbGpPWpGaD
Teniposide—Anorexia—Fluorouracil—skin cancer	0.000284	0.00209	CcSEcCtD
Teniposide—Body temperature increased—Dactinomycin—skin cancer	0.000283	0.00208	CcSEcCtD
Teniposide—Abdominal pain—Dactinomycin—skin cancer	0.000283	0.00208	CcSEcCtD
Teniposide—Hypersensitivity—Bleomycin—skin cancer	0.000283	0.00208	CcSEcCtD
Teniposide—Decreased appetite—Temozolomide—skin cancer	0.000281	0.00207	CcSEcCtD
Teniposide—Flushing—Docetaxel—skin cancer	0.000281	0.00207	CcSEcCtD
Teniposide—ABCG2—lymph node—skin cancer	0.000279	0.0047	CbGeAlD
Teniposide—Hypotension—Fluorouracil—skin cancer	0.000279	0.00205	CcSEcCtD
Teniposide—Asthenia—Bleomycin—skin cancer	0.000275	0.00203	CcSEcCtD
Teniposide—Chills—Docetaxel—skin cancer	0.000272	0.002	CcSEcCtD
Teniposide—Pruritus—Bleomycin—skin cancer	0.000271	0.002	CcSEcCtD
Teniposide—Arrhythmia—Docetaxel—skin cancer	0.000271	0.00199	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—RASA1—skin cancer	0.000269	0.00593	CbGpPWpGaD
Teniposide—Alopecia—Docetaxel—skin cancer	0.000268	0.00197	CcSEcCtD
Teniposide—Feeling abnormal—Temozolomide—skin cancer	0.000267	0.00196	CcSEcCtD
Teniposide—Dyspnoea—Fluorouracil—skin cancer	0.000266	0.00196	CcSEcCtD
Teniposide—Gastrointestinal pain—Temozolomide—skin cancer	0.000265	0.00195	CcSEcCtD
Teniposide—Hypersensitivity—Dactinomycin—skin cancer	0.000264	0.00194	CcSEcCtD
Teniposide—Decreased appetite—Fluorouracil—skin cancer	0.000259	0.00191	CcSEcCtD
Teniposide—Urticaria—Temozolomide—skin cancer	0.000257	0.00189	CcSEcCtD
Teniposide—Asthenia—Dactinomycin—skin cancer	0.000257	0.00189	CcSEcCtD
Teniposide—Body temperature increased—Temozolomide—skin cancer	0.000256	0.00188	CcSEcCtD
Teniposide—Abdominal pain—Temozolomide—skin cancer	0.000256	0.00188	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000253	0.0056	CbGpPWpGaD
Teniposide—Feeling abnormal—Fluorouracil—skin cancer	0.000246	0.00181	CcSEcCtD
Teniposide—Diarrhoea—Dactinomycin—skin cancer	0.000245	0.0018	CcSEcCtD
Teniposide—Vomiting—Bleomycin—skin cancer	0.000244	0.0018	CcSEcCtD
Teniposide—Anaemia—Docetaxel—skin cancer	0.000244	0.00179	CcSEcCtD
Teniposide—Rash—Bleomycin—skin cancer	0.000242	0.00178	CcSEcCtD
Teniposide—Dermatitis—Bleomycin—skin cancer	0.000242	0.00178	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.00024	0.0053	CbGpPWpGaD
Teniposide—Hypersensitivity—Temozolomide—skin cancer	0.000238	0.00175	CcSEcCtD
Teniposide—Urticaria—Fluorouracil—skin cancer	0.000237	0.00174	CcSEcCtD
Teniposide—Leukopenia—Docetaxel—skin cancer	0.000236	0.00174	CcSEcCtD
Teniposide—Body temperature increased—Fluorouracil—skin cancer	0.000236	0.00173	CcSEcCtD
Teniposide—Asthenia—Temozolomide—skin cancer	0.000232	0.00171	CcSEcCtD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—skin cancer	0.000232	0.00512	CbGpPWpGaD
Teniposide—Pruritus—Temozolomide—skin cancer	0.000229	0.00168	CcSEcCtD
Teniposide—Nausea—Bleomycin—skin cancer	0.000228	0.00168	CcSEcCtD
Teniposide—Hypertension—Docetaxel—skin cancer	0.000228	0.00168	CcSEcCtD
Teniposide—Vomiting—Dactinomycin—skin cancer	0.000228	0.00167	CcSEcCtD
Teniposide—Rash—Dactinomycin—skin cancer	0.000226	0.00166	CcSEcCtD
Teniposide—TOP2A—Gastric Cancer Network 2—TP53—skin cancer	0.000225	0.00497	CbGpPWpGaD
Teniposide—Chest pain—Docetaxel—skin cancer	0.000225	0.00165	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—RASA1—skin cancer	0.000222	0.0049	CbGpPWpGaD
Teniposide—Diarrhoea—Temozolomide—skin cancer	0.000221	0.00163	CcSEcCtD
Teniposide—Hypersensitivity—Fluorouracil—skin cancer	0.00022	0.00162	CcSEcCtD
Teniposide—Confusional state—Docetaxel—skin cancer	0.000217	0.0016	CcSEcCtD
Teniposide—Oedema—Docetaxel—skin cancer	0.000215	0.00158	CcSEcCtD
Teniposide—Infection—Docetaxel—skin cancer	0.000214	0.00157	CcSEcCtD
Teniposide—Nausea—Dactinomycin—skin cancer	0.000213	0.00156	CcSEcCtD
Teniposide—Pruritus—Fluorouracil—skin cancer	0.000211	0.00155	CcSEcCtD
Teniposide—Thrombocytopenia—Docetaxel—skin cancer	0.000211	0.00155	CcSEcCtD
Teniposide—Tachycardia—Docetaxel—skin cancer	0.00021	0.00155	CcSEcCtD
Teniposide—Vomiting—Temozolomide—skin cancer	0.000206	0.00151	CcSEcCtD
Teniposide—Anorexia—Docetaxel—skin cancer	0.000205	0.00151	CcSEcCtD
Teniposide—Rash—Temozolomide—skin cancer	0.000204	0.0015	CcSEcCtD
Teniposide—Diarrhoea—Fluorouracil—skin cancer	0.000204	0.0015	CcSEcCtD
Teniposide—Dermatitis—Temozolomide—skin cancer	0.000204	0.0015	CcSEcCtD
Teniposide—Headache—Temozolomide—skin cancer	0.000203	0.00149	CcSEcCtD
Teniposide—Hypotension—Docetaxel—skin cancer	0.000201	0.00148	CcSEcCtD
Teniposide—NCOA1—Leptin signaling pathway—HRAS—skin cancer	0.0002	0.00442	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	0.000197	0.00434	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PLIN2—skin cancer	0.000196	0.00433	CbGpPWpGaD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—TP53—skin cancer	0.000195	0.0043	CbGpPWpGaD
Teniposide—Nausea—Temozolomide—skin cancer	0.000192	0.00141	CcSEcCtD
Teniposide—Dyspnoea—Docetaxel—skin cancer	0.000192	0.00141	CcSEcCtD
Teniposide—Vomiting—Fluorouracil—skin cancer	0.00019	0.0014	CcSEcCtD
Teniposide—Rash—Fluorouracil—skin cancer	0.000188	0.00138	CcSEcCtD
Teniposide—Dermatitis—Fluorouracil—skin cancer	0.000188	0.00138	CcSEcCtD
Teniposide—Decreased appetite—Docetaxel—skin cancer	0.000187	0.00138	CcSEcCtD
Teniposide—Headache—Fluorouracil—skin cancer	0.000187	0.00137	CcSEcCtD
Teniposide—NCOA1—Glucocorticoid receptor regulatory network—IL6—skin cancer	0.000178	0.00394	CbGpPWpGaD
Teniposide—Feeling abnormal—Docetaxel—skin cancer	0.000177	0.00131	CcSEcCtD
Teniposide—Nausea—Fluorouracil—skin cancer	0.000177	0.0013	CcSEcCtD
Teniposide—Gastrointestinal pain—Docetaxel—skin cancer	0.000176	0.0013	CcSEcCtD
Teniposide—Body temperature increased—Docetaxel—skin cancer	0.00017	0.00125	CcSEcCtD
Teniposide—Abdominal pain—Docetaxel—skin cancer	0.00017	0.00125	CcSEcCtD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDK4—skin cancer	0.000163	0.0036	CbGpPWpGaD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—KRAS—skin cancer	0.000163	0.00359	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PLIN2—skin cancer	0.000162	0.00358	CbGpPWpGaD
Teniposide—Hypersensitivity—Docetaxel—skin cancer	0.000159	0.00117	CcSEcCtD
Teniposide—NCOA3—Metabolism—CSPG4—skin cancer	0.000158	0.00349	CbGpPWpGaD
Teniposide—Asthenia—Docetaxel—skin cancer	0.000154	0.00114	CcSEcCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—KRAS—skin cancer	0.000154	0.0034	CbGpPWpGaD
Teniposide—Pruritus—Docetaxel—skin cancer	0.000152	0.00112	CcSEcCtD
Teniposide—Diarrhoea—Docetaxel—skin cancer	0.000147	0.00108	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—TP53—skin cancer	0.000145	0.00319	CbGpPWpGaD
Teniposide—Vomiting—Docetaxel—skin cancer	0.000137	0.00101	CcSEcCtD
Teniposide—Rash—Docetaxel—skin cancer	0.000136	0.000999	CcSEcCtD
Teniposide—Dermatitis—Docetaxel—skin cancer	0.000136	0.000998	CcSEcCtD
Teniposide—Headache—Docetaxel—skin cancer	0.000135	0.000992	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—CDK4—skin cancer	0.000132	0.00291	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CSPG4—skin cancer	0.000131	0.00289	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—HRAS—skin cancer	0.000131	0.00289	CbGpPWpGaD
Teniposide—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	0.00013	0.00288	CbGpPWpGaD
Teniposide—Nausea—Docetaxel—skin cancer	0.000128	0.000941	CcSEcCtD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDKN2A—skin cancer	0.000125	0.00275	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000124	0.00273	CbGpPWpGaD
Teniposide—NCOA1—Adipogenesis—IL6—skin cancer	0.000123	0.00272	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—CDK4—skin cancer	0.000119	0.00262	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CDK4—skin cancer	0.000109	0.00241	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—ENO2—skin cancer	0.000107	0.00237	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000106	0.00234	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—MLH1—skin cancer	0.000105	0.00232	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—skin cancer	9.85e-05	0.00218	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—ENO2—skin cancer	8.89e-05	0.00196	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	8.83e-05	0.00195	CbGpPWpGaD
Teniposide—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	8.7e-05	0.00192	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.41e-05	0.00186	CbGpPWpGaD
Teniposide—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	7.93e-05	0.00175	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—NRAS—skin cancer	7.32e-05	0.00162	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.95e-05	0.00154	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—ERCC2—skin cancer	6.64e-05	0.00147	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	6.52e-05	0.00144	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—KRAS—skin cancer	6.3e-05	0.00139	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—ERCC2—skin cancer	6.24e-05	0.00138	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—NRAS—skin cancer	6.06e-05	0.00134	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDK4—skin cancer	5.98e-05	0.00132	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TERT—skin cancer	5.97e-05	0.00132	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	5.94e-05	0.00131	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	5.91e-05	0.00131	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HRAS—skin cancer	5.36e-05	0.00118	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDK4—skin cancer	5.35e-05	0.00118	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	5.25e-05	0.00116	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PLIN2—skin cancer	5.24e-05	0.00116	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—KRAS—skin cancer	5.21e-05	0.00115	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—ERCC2—skin cancer	5.16e-05	0.00114	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—IL6—skin cancer	5.13e-05	0.00113	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—skin cancer	5.04e-05	0.00111	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—IL6—skin cancer	4.62e-05	0.00102	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN2A—skin cancer	4.57e-05	0.00101	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—HRAS—skin cancer	4.43e-05	0.000979	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—IL6—skin cancer	4.24e-05	0.000937	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CSPG4—skin cancer	4.22e-05	0.000932	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN2A—skin cancer	4.09e-05	0.000902	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PLIN2—skin cancer	3.75e-05	0.000829	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PTGS2—skin cancer	3.74e-05	0.000827	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PTGS2—skin cancer	3.1e-05	0.000684	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CSPG4—skin cancer	3.03e-05	0.000668	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PLIN2—skin cancer	2.9e-05	0.000641	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ENO2—skin cancer	2.87e-05	0.000634	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PLIN2—skin cancer	2.65e-05	0.000584	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CSPG4—skin cancer	2.34e-05	0.000516	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—skin cancer	2.27e-05	0.000502	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CSPG4—skin cancer	2.13e-05	0.000471	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ENO2—skin cancer	2.06e-05	0.000454	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PLIN2—skin cancer	1.74e-05	0.000385	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—ERCC2—skin cancer	1.67e-05	0.000368	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ENO2—skin cancer	1.59e-05	0.000351	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ENO2—skin cancer	1.45e-05	0.00032	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CSPG4—skin cancer	1.41e-05	0.000311	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.24e-05	0.000275	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—ERCC2—skin cancer	1.19e-05	0.000264	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.13e-05	0.00025	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PTGS2—skin cancer	1e-05	0.000221	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ENO2—skin cancer	9.56e-06	0.000211	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—ERCC2—skin cancer	9.24e-06	0.000204	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—ERCC2—skin cancer	8.42e-06	0.000186	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PTGS2—skin cancer	7.16e-06	0.000158	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—ERCC2—skin cancer	5.55e-06	0.000123	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PTGS2—skin cancer	5.54e-06	0.000122	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PTGS2—skin cancer	5.05e-06	0.000111	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PTGS2—skin cancer	3.33e-06	7.35e-05	CbGpPWpGaD
